Citations (79)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Raj Kumar Singh, Kuldeep Dhama, Yashpal Singh Malik, Muthannan Andavar Ramakrishnan, Kumaragurubaran Karthik, Rekha Khandia, Ruchi Tiwari, Ashok Munjal, Mani Saminathan, Swati Sachan, Perumal Arumugam Desingu, Jobin Jose Kattoor, Hafiz M.N. Iqbal & Sunil Kumar Joshi. (2017) Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey. Veterinary Quarterly 37:1, pages 98-135.
Read now
Read now
Christopher L Cooper, Karen A Martins, Sabrina M Stronsky, David P Langan, Jesse Steffens, Sean Van Tongeren & Sina Bavari. (2017) T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection. Emerging Microbes & Infections 6:1, pages 1-9.
Read now
Read now
Frank Sainsbury. (2014) Meeting Report VLPNPV: Sessions 1 and 2: Plenary. Human Vaccines & Immunotherapeutics 10:10, pages 3060-3063.
Read now
Read now
Gary Wong & Gary Kobinger. (2012) A strategy to simultaneously eradicate the natural reservoirs of rabies and Ebola virus. Expert Review of Vaccines 11:2, pages 163-166.
Read now
Read now
Articles from other publishers (75)
Manish P Mane Manohar, Vivian J Lee, Ejikeme U Chinedum Odunukwe, Pratik K Singh, Buhlebethu S Mpofu & Christine Oxley, MD. (2023) Advancements in Marburg (MARV) Virus Vaccine Research With Its Recent Reemergence in Equatorial Guinea and Tanzania: A Scoping Review. Cureus.
Crossref
Crossref
Verena Krähling, Stephanie Erbar, Alexandra Kupke, Sara S. Nogueira, Kerstin C. Walzer, Hendrik Berger, Erik Dietzel, Sandro Halwe, Cornelius Rohde, Lucie Sauerhering, Letícia Aragão-Santiago, Jorge Moreno Herrero, Sonja Witzel, Heinrich Haas, Stephan Becker & Ugur Sahin. (2023) Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection. Molecular Therapy 31:2, pages 374-386.
Crossref
Crossref
Amanda N Pinski & Ilhem Messaoudi. (2021) Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity. Current Opinion in Virology 51, pages 179-189.
Crossref
Crossref
Olivier Tshiani Mbaya, Philippe Mukumbayi & Sabue Mulangu. (2021) Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection. Frontiers in Immunology 12.
Crossref
Crossref
Oyewale Tomori & Matthew Olatunji Kolawole. (2021) Ebola virus disease: current vaccine solutions. Current Opinion in Immunology 71, pages 27-33.
Crossref
Crossref
Mark G. Kortepeter, Kerry Dierberg, Erica S. Shenoy & Theodore J. Cieslak. (2020) Marburg virus disease: A summary for clinicians. International Journal of Infectious Diseases 99, pages 233-242.
Crossref
Crossref
A. Ndjoyi-Mbiguino, S. Zoa-Assoumou, G. Mourembou & Moulay Mustapha Ennaji. 2020. Emerging and Reemerging Viral Pathogens. Emerging and Reemerging Viral Pathogens
201
218
.
Kristel L. Emmer & Hildegund C.J. Ertl. 2020. Mucosal Vaccines. Mucosal Vaccines
419
444
.
Shengnan Xu, Cuicui Jiao, Hongli Jin, Wujian Li, Entao Li, Zengguo Cao, Zhikang Shi, Feihu Yan, Shengnan Zhang, Hongbin He, Hang Chi, Na Feng, Yongkun Zhao, Yuwei Gao, Songtao Yang, Jianzhong Wang, Hualei Wang & Xianzhu Xia. (2019) A Novel Bacterium-Like Particle-Based Vaccine Displaying the SUDV Glycoprotein Induces Potent Humoral and Cellular Immune Responses in Mice. Viruses 11:12, pages 1149.
Crossref
Crossref
Yuki Takamatsu, Olga Dolnik, Takeshi Noda & Stephan Becker. (2019) A live-cell imaging system for visualizing the transport of Marburg virus nucleocapsid-like structures. Virology Journal 16:1.
Crossref
Crossref
Qiu-dong Su, Shi-hua He, Yao Yi, Feng Qiu, Xue-xin Lu, Zhi-yuan Jia, Qing-ling Meng, Xue-ting Fan, Rui-guang Tian, Jonathan Audet, Xiang-guo Qiu & Sheng-li Bi. (2018) Intranasal vaccination with ebola virus GP amino acids 258–601 protects mice against lethal challenge. Vaccine 36:41, pages 6053-6060.
Crossref
Crossref
Adrián Lázaro-Frías, Sergio Gómez-Medina, Lucas Sánchez-Sampedro, Karl Ljungberg, Mart Ustav, Peter Liljeström, César Muñoz-Fontela, Mariano Esteban & Juan García-Arriaza. (2018) Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Journal of Virology 92:11.
Crossref
Crossref
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald, Ulrike Dirmeier, Cedric Cheminay, Ariane Volkmann, Trevor Brasel, Ricardo Carrion, Luis D. Giavedoni, Jean L. Patterson, Chad E. Mire, Thomas W. Geisbert, Jay W. Hooper, Mo Weijtens, Jutta Hartkoorn-Pasma, Jerome Custers, Maria Grazia Pau, Hanneke Schuitemaker & Roland Zahn. (2018) A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. PLOS ONE 13:2, pages e0192312.
Crossref
Crossref
Demetrius Matassov, Chad E. Mire, Theresa Latham, Joan B. Geisbert, Rong Xu, Ayuko Ota-Setlik, Krystle N. Agans, Dean J. Kobs, Morgan Q. S. Wendling, Amanda Burnaugh, Thomas L. RudgeJr.Jr., Carol L. Sabourin, Michael A. Egan, David K. Clarke, Thomas W. Geisbert & John H. Eldridge. (2018) Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge. Journal of Virology 92:3.
Crossref
Crossref
Yuki TakamatsuLarissa KolesnikovaStephan Becker. (2018) Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport. Proceedings of the National Academy of Sciences 115:5, pages 1075-1080.
Crossref
Crossref
Arban Domi, Friederike Feldmann, Rahul Basu, Nathanael McCurley, Kyle Shifflett, Jackson Emanuel, Michael S. Hellerstein, Farshad Guirakhoo, Chiara Orlandi, Robin Flinko, George K. Lewis, Patrick W. Hanley, Heinz Feldmann, Harriet L. Robinson & Andrea Marzi. (2018) A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge. Scientific Reports 8:1.
Crossref
Crossref
Weiwei Gai, Xuexing Zheng, Chong Wang, Hualei Wang, Yongkun Zhao, Qi Wang, Gary Wong, Weijiao Zhang, Na Feng, Boning Qiu, Hang Chi, Nan Li, Tiecheng Wang, Yuwei Gao, Junjie Shan, Songtao Yang & Xianzhu Xia. (2017) Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in mice. Virology Journal 14:1.
Crossref
Crossref
Behzad Dehghani, Farzane Ghasabi, Tayebeh Hashempoor, Hassan Joulaei, Zahra Hasanshahi, Mehrdad Halaji, Nazanin Chatrabnous, Zahra Mousavi & Javad Moayedi. (2017)
Functional and structural characterization of Ebola virus glycoprotein (1976–2015) — An
in silico
study
. International Journal of Biomathematics 10:08, pages 1750108.
Crossref
Crossref
Marc Schweneker, Andrea S. Laimbacher, Gert Zimmer, Susanne Wagner, Elisabeth M. Schraner, Michael Wolferstätter, Marieken Klingenberg, Ulrike Dirmeier, Robin Steigerwald, Henning Lauterbach, Hubertus Hochrein, Paul Chaplin, Mark Suter & Jürgen Hausmann. (2017) Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles. Journal of Virology 91:11.
Crossref
Crossref
Gang Chen, Sachdev S. Sidhu & Johan Nilvebrant. 2017. Recombinant Antibodies for Infectious Diseases. Recombinant Antibodies for Infectious Diseases
79
98
.
David K. Clarke, R. Michael Hendry, Vidisha Singh, John K. Rose, Stephen J. Seligman, Bettina Klug, Sonali Kochhar, Lisa Marie Mac, Baevin Carbery & Robert T. Chen. (2016) Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment. Vaccine 34:51, pages 6597-6609.
Crossref
Crossref
Nadine Biedenkopf, Julia Schlereth, Arnold Grünweller, Stephan Becker & Roland K. Hartmann. (2016) RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription. Journal of Virology 90:16, pages 7481-7496.
Crossref
Crossref
Andrea Marzi, Aisling A. Murphy, Friederike Feldmann, Christopher J. Parkins, Elaine Haddock, Patrick W. Hanley, Matthew J. Emery, Flora Engelmann, Ilhem Messaoudi, Heinz Feldmann & Michael A. Jarvis. (2016) Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection. Scientific Reports 6:1.
Crossref
Crossref
Arti Vashist, Ajeet Kaushik, Atul Vashist, Rahul Dev Jayant, Asahi Tomitaka, Sharif Ahmad, Y. K. Gupta & Madhavan Nair. (2016) Recent trends on hydrogel based drug delivery systems for infectious diseases. Biomaterials Science 4:11, pages 1535-1553.
Crossref
Crossref
Elijah Ige Ohimain. (2016) Recent advances in the development of vaccines for Ebola virus disease. Virus Research 211, pages 174-185.
Crossref
Crossref
Michael Osterholm, Kristine Moore, Julie Ostrowsky, Kathleen Kimball-Baker & Jeremy Farrar. (2016) The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats. The Lancet Infectious Diseases 16:1, pages e1-e9.
Crossref
Crossref
Daniel G. Bausch & Marguerite M. Clougherty. (2015) Ebola Virus: Sensationalism, Science, and Human Rights: Table 1.. Journal of Infectious Diseases 212:suppl 2, pages S79-S83.
Crossref
Crossref
Demetrius Matassov, Andrea Marzi, Terri Latham, Rong Xu, Ayuko Ota-Setlik, Friederike Feldmann, Joan B. Geisbert, Chad E. Mire, Stefan Hamm, Becky Nowak, Michael A. Egan, Thomas W. Geisbert, John H. Eldridge, Heinz Feldmann & David K. Clarke. (2015) Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus. Journal of Infectious Diseases 212:suppl 2, pages S443-S451.
Crossref
Crossref
Allison Groseth, Markus Eickmann, Hideki Ebihara, Stephan Becker & Thomas Hoenen. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
13
.
O. I. Kiselev, A. V. Vasin, M. P. Shevyryova, E. G. Deeva, K. V. Sivak, V. V. Egorov, V. B. Tsvetkov, A. Yu. Egorov, E. A. Romanovskaya-Romanko, L. A. Stepanova, A. B. Komissarov, L. M. Tsybalova & G. M. Ignatjev. (2015) Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents. Molecular Biology 49:4, pages 480-493.
Crossref
Crossref
Jessica N Hartnett, Matthew L Boisen, Darin Oottamasathien, Abigail B Jones, Molly M Millett, Diana S Nelson, Ivana J Muncy, Augustine Goba, Mambu Momoh, Mohammed Fullah, Chad E Mire, Joan B Geisbert, Thomas W Geisbert, Debra L Holton, Julie A Rouelle, Chandrika B Kannadka, Ashley A Reyna, Lina M Moses, Sheik Humarr Khan, Sahr M Gevao, Donald S Grant, James E Robinson, Christian Happi, Kelly R Pitts, Robert F Garry & Luis M Branco. (2015) Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever. Future Virology 10:5, pages 559-584.
Crossref
Crossref
Woo Young Choi, Kee-Jong Hong, Joo Eun Hong & Won-Ja Lee. (2015) Progress of vaccine and drug development for Ebola preparedness. Clinical and Experimental Vaccine Research 4:1, pages 11.
Crossref
Crossref
Sophie L Wang, Upendra Chitgupi & Jonathan F Lovell. (2015) Highlights from the latest research in nanomedicine. Nanomedicine 10:1, pages 5-8.
Crossref
Crossref
NORIO YAMAMOTO. (2015) An Overview of Ebola Virus Disease: History, Pathogenesis, and Treatment. Juntendo Medical Journal 61:4, pages 396-406.
Crossref
Crossref
Thomas W. Geisbert. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1995
1999.e1
.
Charles D. Murin, Marnie L. Fusco, Zachary A. Bornholdt, Xiangguo QiuGene G. OlingerLarry ZeitlinGary P. Kobinger, Andrew B. WardErica Ollmann Saphire. (2014) Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proceedings of the National Academy of Sciences 111:48, pages 17182-17187.
Crossref
Crossref
Kang Yiu Lai, Wing Yiu George Ng & Fan Fanny Cheng. (2014) Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infectious Diseases of Poverty 3:1.
Crossref
Crossref
Stuart D Dowall, David A Matthews, Isabel García-Dorival, Irene Taylor, John Kenny, Christiane Hertz-Fowler, Neil Hall, Kara Corbin-Lickfett, Cyril Empig, Kyle Schlunegger, John N Barr, Miles W Carroll, Roger Hewson & Julian A Hiscox. (2014) Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity. Genome Biology 15:11.
Crossref
Crossref
Amir Attaran & Jason W Nickerson. (2014) Is Canada patent deal obstructing Ebola vaccine development?. The Lancet 384:9958, pages e61.
Crossref
Crossref
Clive M. Gray, Marylyn Addo & Reinhold E. Schmidt. (2014) A Dead-End Host: Is There a Way Out? A Position Piece on the Ebola Virus Outbreak by the International Union of Immunology Societies. Frontiers in Immunology 5.
Crossref
Crossref
Emily P. ThiChad E. MireRaul Ursic-BedoyaJoan B. GeisbertAmy C. H. LeeKrystle N. AgansMarjorie RobbinsDaniel J. DeerKarla A. FentonIan MacLachlanThomas W. Geisbert. (2014) Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA. Science Translational Medicine 6:250.
Crossref
Crossref
Chad E. Mire, Joan B. Geisbert, Krystle N. Agans, Benjamin A. Satterfield, Krista M. Versteeg, Elizabeth A. Fritz, Heinz Feldmann, Lisa E. Hensley & Thomas W. Geisbert. (2014) Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates. PLoS ONE 9:4, pages e94355.
Crossref
Crossref
Lyn M. O'Brien, Margaret G. Stokes, Stephen G. Lonsdale, David R. Maslowski, Sophie J. Smither, Mark S. Lever, Thomas R. Laws & Stuart D. Perkins. (2014) Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse. Virology 452-453, pages 324-333.
Crossref
Crossref
Karen A. O. Martins, Jesse T. Steffens, Sean A. van Tongeren, Jay B. Wells, Alison A. Bergeron, Samuel P. Dickson, John M. Dye, Andres M. Salazar & Sina Bavari. (2014) Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation. PLoS ONE 9:2, pages e89735.
Crossref
Crossref
Lucille Blumberg, Delia Enria & Daniel G. Bausch. 2014. Manson's Tropical Infectious Diseases. Manson's Tropical Infectious Diseases
171
194.e2
.
Pierre Formenty. 2014. Emerging Infectious Diseases. Emerging Infectious Diseases
121
134
.
Xiangguo Qiu, Jonathan Audet, Gary Wong, Lisa Fernando, Alexander Bello, Stéphane Pillet, Judie B. Alimonti & Gary P. Kobinger. (2013) Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Scientific Reports 3:1.
Crossref
Crossref
Xiangguo Qiu, Gary Wong, Lisa Fernando, Jane Ennis, Jeffrey D. Turner, Judie B. Alimonti, Xiaojian Yao & Gary P. Kobinger. (2013) Monoclonal Antibodies Combined with Adenovirus-Vectored Interferon Significantly Extend the Treatment Window in Ebola Virus-Infected Guinea Pigs. Journal of Virology 87:13, pages 7754-7757.
Crossref
Crossref
Devon J Shedlock, Jenna Aviles, Kendra T Talbott, Gary Wong, Stephan J Wu, Daniel O Villarreal, Devin JF Myles, Maria A Croyle, Jian Yan, Gary P Kobinger & David B Weiner. (2013) Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola. Molecular Therapy 21:7, pages 1432-1444.
Crossref
Crossref
Darryl Falzarano & Heinz Feldmann. (2013) Vaccines for viral hemorrhagic fevers—progress and shortcomings. Current Opinion in Virology 3:3, pages 343-351.
Crossref
Crossref
Andrew S. Herbert, Ana I. Kuehne, James F. Barth, Ramon A. Ortiz, Donald K. Nichols, Samantha E. Zak, Spencer W. Stonier, Majidat A. Muhammad, Russell R. Bakken, Laura I. Prugar, Gene G. Olinger, Jennifer L. Groebner, John S. Lee, William D. Pratt, Max Custer, Kurt I. Kamrud, Jonathan F. Smith, Mary Kate Hart & John M. Dye. (2013) Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus. Journal of Virology 87:9, pages 4952-4964.
Crossref
Crossref
Nadine Biedenkopf, Bettina Hartlieb, Thomas Hoenen & Stephan Becker. (2013) Phosphorylation of Ebola Virus VP30 Influences the Composition of the Viral Nucleocapsid Complex. Journal of Biological Chemistry 288:16, pages 11165-11174.
Crossref
Crossref
Marc Gurwith, Michael Lock, Eve M Taylor, Glenn Ishioka, Jeff Alexander, Tim Mayall, John E Ervin, Richard N Greenberg, Cynthia Strout, John J Treanor, Richard Webby & Peter F Wright. (2013) Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study. The Lancet Infectious Diseases 13:3, pages 238-250.
Crossref
Crossref
Andrea MarziFlora EngelmannFriederike Feldmann, Kristen HaberthurW. Lesley ShupertDouglas BriningDana P. ScottThomas W. GeisbertYoshihiro KawaokaMichael G. Katze, Heinz FeldmannIlhem Messaoudi. (2013) Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates. Proceedings of the National Academy of Sciences 110:5, pages 1893-1898.
Crossref
Crossref
Gopi S. Mohan, Wenfang Li, Ling Ye, Richard W. Compans & Chinglai Yang. (2012) Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus. PLoS Pathogens 8:12, pages e1003065.
Crossref
Crossref
Wu Ou, Josie Delisle, Jerome Jacques, Joanna Shih, Graeme Price, Jens H Kuhn, Vivian Wang, Daniela Verthelyi, Gerardo Kaplan & Carolyn A Wilson. (2012) Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain. Virology Journal 9:1.
Crossref
Crossref
Alexander Ghanem & Karl‐Klaus Conzelmann. 2012. Reverse Genetics of RNA Viruses. Reverse Genetics of RNA Viruses
113
149
.
Igor Lukashevich. (2012) Advanced Vaccine Candidates for Lassa Fever. Viruses 4:11, pages 2514-2557.
Crossref
Crossref
Gianluca Pegoraro, Sina Bavari & Rekha G. Panchal. (2012) Shedding Light on Filovirus Infection with High-Content Imaging. Viruses 4:8, pages 1354-1371.
Crossref
Crossref
Erin N. Hodges, Bianca S. Heinrich & John H. Connor. (2012)
A Vesiculovirus Showing a Steepened Transcription Gradient and Dominant
trans
-Repression of Virus Transcription
. Journal of Virology 86:16, pages 8884-8889.
Crossref
Crossref
Adam MacNeil & Pierre E. Rollin. (2012) Ebola and Marburg Hemorrhagic Fevers: Neglected Tropical Diseases?. PLoS Neglected Tropical Diseases 6:6, pages e1546.
Crossref
Crossref
Aparna Talekar, Antonello Pessi, Fraser Glickman, Uttara Sengupta, Thomas Briese, Michael A. Whitt, Cyrille Mathieu, Branka Horvat, Anne Moscona & Matteo Porotto. (2012) Rapid Screening for Entry Inhibitors of Highly Pathogenic Viruses under Low-Level Biocontainment. PLoS ONE 7:3, pages e30538.
Crossref
Crossref
Luca Zinzula, Francesca Esposito, Daniela Pala & Enzo Tramontano. (2012) dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35. Antiviral Research 93:3, pages 354-363.
Crossref
Crossref
Rekha G. Panchal, St. Patrick Reid, Julie P. Tran, Alison A. Bergeron, Jay Wells, Krishna P. Kota, Javad Aman & Sina Bavari. (2012) Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. Antiviral Research 93:1, pages 23-29.
Crossref
Crossref
Margot Anderson & Daniel G. Bausch. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1159
1164.e2
.
Daniel G. Bausch. 2012. Goldman's Cecil Medicine. Goldman's Cecil Medicine
2147
2156
.
Waranyoo PhoolcharoenJohn M. DyeJacquelyn KilbourneKhanrat PiensookWilliam D. PrattCharles J. ArntzenQiang Chen, Hugh S. MasonMelissa M. Herbst-Kralovetz. (2011) A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proceedings of the National Academy of Sciences 108:51, pages 20695-20700.
Crossref
Crossref
Allison Groseth, Thomas Hoenen, Markus Eickmann & Stephan Becker. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Rebecca J. Grant-Klein, Louis A. Altamura & Connie S. Schmaljohn. (2011) Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses. Virus Research 162:1-2, pages 148-161.
Crossref
Crossref
Shridhar Bale, Tong Liu, Sheng Li, Yuhao Wang, Dafna Abelson, Marnie Fusco, Virgil L. Woods & Erica Ollmann Saphire. (2011) Ebola Virus Glycoprotein Needs an Additional Trigger, beyond Proteolytic Priming for Membrane Fusion. PLoS Neglected Tropical Diseases 5:11, pages e1395.
Crossref
Crossref
Yoshimi Tsuda, David Safronetz, Kyle Brown, Rachel LaCasse, Andrea Marzi, Hideki Ebihara & Heinz Feldmann. (2011) Protective Efficacy of a Bivalent Recombinant Vesicular Stomatitis Virus Vaccine in the Syrian Hamster Model of Lethal Ebola Virus Infection. The Journal of Infectious Diseases 204:suppl_3, pages S1090-S1097.
Crossref
Crossref
Andrea Marzi, Hideki Ebihara, Julie Callison, Allison Groseth, Kinola J. Williams, Thomas W. Geisbert & Heinz Feldmann. (2011) Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy. The Journal of Infectious Diseases 204:suppl_3, pages S1066-S1074.
Crossref
Crossref
Yoshimi Tsuda, Patrizia Caposio, Christopher J. Parkins, Sara Botto, Ilhem Messaoudi, Luka Cicin-Sain, Heinz Feldmann & Michael A. Jarvis. (2011) A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus. PLoS Neglected Tropical Diseases 5:8, pages e1275.
Crossref
Crossref
Sonia M. Gregory, Erisa Harada, Binyong Liang, Sue E. Delos, Judith M. White & Lukas K. Tamm. (2011) Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proceedings of the National Academy of Sciences 108:27, pages 11211-11216.
Crossref
Crossref
Kelly Lyn Warfield & Gene Garrard Olinger. (2011) Protective Role of Cytotoxic T Lymphocytes in Filovirus Hemorrhagic Fever. Journal of Biomedicine and Biotechnology 2011, pages 1-13.
Crossref
Crossref